Indian drug giant Ranbaxy makes bid for the generic drugs unit of Merck KGaA in Germany
The leading Indian drugmaker Ranbaxy Laboratories Ltd. said on Tuesday it has submitted a bid for the generics unit of Germany’s Merck KGaA. The buy-out of the unit could be worth as much as 5 billion Euros (US $6.58 billion), analysts say. The company has submitted its bid to the German drug and chemical maker, [...]
Read User's Comments(0)